Machine learning predictions based on historical earnings data and price patterns
1-Day Prediction
-0.42%
$11.82
0% positive prob.
5-Day Prediction
-5.64%
$11.20
0% positive prob.
20-Day Prediction
-1.99%
$11.63
0% positive prob.
| Quarter | Signal | 1D Return | 5D Return | 20D Return | Confidence | Actual 5D |
|---|---|---|---|---|---|---|
| Q3 2026 | SELL | -0.42% | -5.64% | -1.99% | 100.0% | Pending |
| Q2 2026 | BUY | +4.23% | +7.00% | +15.92% | 100.0% | Pending |
| Q1 2026 | SELL | -0.37% | -5.76% | -1.82% | 100.0% | -7.92% |
| Q4 2025 | SELL | -0.39% | -6.06% | -3.01% | 100.0% | -2.47% |
SEC 8-K filings with transcript text
Oct 6, 2026 · 100% conf.
1D
-0.42%
$11.82
Act: -1.60%
5D
-5.64%
$11.20
20D
-1.99%
$11.63
2 neog-ex99_1.htm
Exhibit 99.1
Neogen Reports First-Quarter Financial Results for Fiscal Year 2027
• Revenue of $222.8 million, representing growth of 6.5% and Core Growth1 of 8.1%
• Food Safety revenue growth of 7.4%, including Core Growth1 of 8.1%
• Animal Safety revenue growth of 4.2%, including Core Growth1 of 8.0%
• Net loss of $11.9 million with EPS of $(0.05); Adjusted Net Income1 of $17.5 million with Adjusted EPS1 of $0.08
• Cash flow from operations of $12.9 million and free cash flow of $4.7 million
• Adjusted EBITDA1 of $41.6 million, with Adjusted EBITDA1 margin of 18.7%
• Company on track to manufacture saleable Petrifilm® product and begin planned multi-quarter manufacturing transition in November 2026; first single kit unit (SKU) fully validated
• Raising fiscal year 2027 financial guidance for revenue and Adjusted EBITDA1
1 Non-GAAP financial measures; see explanations and reconciliations that follow
LANSING, October 6, 2026 – Neogen® Corporation (NASDAQ: NEOG), an innovative leader in food safety solutions, announced its financial results for the first quarter of fiscal year 2027.
“As we entered fiscal year 2027, our focus shifted from strengthening fundamentals to scaling them to drive more consistent execution, improved customer outcomes and profitable growth,” said Mike Nassif, Neogen’s President and Chief Executive Officer. “Our first-quarter results reflect encouraging progress as the changes underway across the organization continue to take hold. We are strengthening commercial discipline, harmonizing our sales operating model, rebuilding our innovation engine and improving the systems and processes that support inventory optimization and customer service. At the same time, we are making targeted investments to enhance our capabilities and are committed to pursuing further improvements with the goal of building on our momentum to drive more consistent growth and margin expansion over the long term.”
Financial Highlights
Revenue by Products and Geography
Three months ended August 31,
2026
2025
Food Safety
Natural Toxins & Allergens
$
19.3
$
20.0
Bacterial & General Sanitation
44.6
41.6
Indicator Testing & Culture Media
85.6
76.8
Biosecurity Products
4.6
5.8
Genomics Services
6.7
5.6
Other
2.4
2.3
Total Food Safety Revenue
$
163.2
$
152.1
Animal Safety
Life Sciences
$
1.6
$
1.9
Veterinary Instruments & Consumables
14.1
11.9
Animal Care & Other
7.7
7.6
Biosecurity Products
18.9
19.2
Genomics Services
17.3
16.5
Total Animal Safety Revenue
59.6
57.1
Total Revenues
$
222.8
$
209.2
Three months ended August 31,
2026
2025
Domestic
$
110.1
$
102.1
International
112.7
107.1
Total revenue
$
222.8
$
209.2
• Revenues for the first quarter were $222.8 million, growth of 6.5% when compared to $209.2 million in the prior-year first quarter. Core revenue, which excludes the impacts of foreign currency translation, as well as divestitures completed and product lines discontinued in the last 12 months, increased by 8.1%. The core revenue increase includes a benefit of approximately 3% related to inventory adjustments at certain distributors in the prior-year quarter and the timing of certain customer orders in the first quarter of fiscal year 2027.
• Food Safety segment revenue was $163.2 million in the first quarter, increasing 7.4% relative to the first quarter of fiscal year 2026, and included core revenue growth of 8.1%. The Company saw continued strong growth in Indicator Testing and Culture Media, including Petrifilm, and Bacterial and General Sanitation, including pathogen detection products.
• Animal Safety segment revenue was $59.6 million in the first quarter, representing growth of 4.2% relative to the first quarter of fiscal year 2026, and included core revenue growth of 8.0%. The Company saw strong growth in Veterinary Instruments & Consumables, as well as in Biosecurity Products, primarily from insect control products.
• Domestic revenue in the quarter was $110.1 million and international revenue was $112.7 million. Compared to the first quarter of fiscal year 2026, the Company saw growth in all regions globally, including double-digit growth in Asia Pacific.
Summary of Income Statement
Three months ended August 31,
2026
2025
Revenue
$
222.8
$
209.2
Cost of Revenues
117.3
114.2
Gross Profit
105.5
95.0
Gross Margin
47.4
%
45.4
%
Operating Expenses
107.3
111.1
Operating Loss
$
(1.8
)
$
(16.1
)
Operating Margin
(0.8
)%
(7.7
)%
Net (Loss) Income
$
(11.9
)
$
36.3
Net (Loss) Earnings Per Share
$
(0.05
)
$
0.17
Non-GAAP Financial Measures
$
28.0
$
88.4
EBITDA Margin
12.6
%
42.3
%
Adjusted Gross Profit
$
110.9
$
103.6
Adjusted Gross Margin
49.8
%
49.5
%
Adjusted Operating Income
$
36.5
$
29.6
Adjusted Operating Margin
16.4
%
14.1
%
Adjusted EBITDA
$
41.6
$
35.5
Adjusted EBITDA Margin
18.7
%
Jul 30, 2026 · 100% conf.
1D
+4.23%
$9.80
Act: +4.42%
5D
+7.00%
$10.06
20D
+15.92%
$10.90
2 neog-ex99_1.htm
Exhibit 99.1
Neogen Reports Fourth Quarter and Full Fiscal Year 2026 Financial Results
Delivered Strong Core Growth in Q4 FY26 with Food Safety Core Growth Highest Since FY23
• Fiscal fourth quarter 2026 revenue of $225.3 million representing growth of (0.1%) and Core Growth1 of 4.3%; Full fiscal year 2026 revenue of $870.4 million with growth of (2.7%) and Core Growth1 of 1.9%
• Food Safety fourth quarter revenue growth of 3.1% and Core Growth1 of 5.8%; highest quarterly core growth rate since FY 2023
• Animal Safety fourth quarter revenue growth of (8.2%), Core Growth1 of 0.5%; revenue grew 7% sequentially due to resolution of the majority of supply challenges
• Net loss of $11.3 million in the fourth quarter 2026 with EPS of $(0.05); Adjusted Net Income1 of $18.7 million and Adjusted EPS1 of $0.09
• Fourth quarter 2026 cash flow from operations of $30.2 million and free cash flow of $26.2 million
• Fourth quarter 2026 Adjusted EBITDA1 of $45.4 million; with Adjusted EBITDA1 margin of 20.2%
• Company on track to manufacture sellable Petrifilm® product and begin planned multi-quarter manufacturing transition in November 2026; first completed fully validated single kit unit (SKU) expected by the end of August 2026
• Company provides FY 2027 financial guidance for revenue and Adjusted EBITDA1
1 Non-GAAP financial measures; see explanations and reconciliations that follow
LANSING, July 30, 2026 – Neogen® Corporation (NASDAQ: NEOG), an innovative leader in food safety solutions, announced its financial results for the fiscal fourth quarter and full fiscal year 2026 and provided financial guidance for its fiscal year first quarter and full fiscal year 2027.
“We ended fiscal year 2026 with significant momentum and have a number of initiatives underway to further enhance our commercial efforts and the way we approach customers and our core markets. Fiscal year 2027 will be a year of disciplined execution and investment in core areas as we look to drive high-impact innovation and operational efficiency through additive technology and improved process. Ultimately, our goal is to exit FY27 positioned for enhanced future growth and profitability," said Mike Nassif, Neogen’s President and Chief Executive Officer.
He continued, “We are providing our fiscal guidance for 2027, and we have stayed true to our principles of delivering on our commitments. Our entire organization is focused on disciplined execution and sustaining the operational momentum that we have seen in the business throughout fiscal year 2026. I’m extremely proud of our team and want to thank our employees for their significant contributions to the success of our company.”
Financial Highlights
Revenue by Products and Geography
Three months ended May 31,
Twelve months ended May 31,
(in millions)
2026
2025
% Change
2026
2025
% Change
Food Safety:
Natural Toxins & Allergens
$
19.2
$
18.5
3.8
%
$
77.5
$
77.0
0.6
%
Bacterial & General Sanitation
46.7
42.5
9.9
%
175.4
164.8
6.4
%
Indicator Testing, Culture Media
86.8
79.3
9.5
%
332.7
312.2
6.6
%
Rodent Control, Insect Control & Disinfectants
3.9
11.3
(65.5
)%
18.2
47.0
(61.3
)%
Genomics Services
6.6
6.3
4.8
%
24.6
23.4
5.1
%
Other
3.6
3.9
(7.7
)%
12.7
13.7
(7.3
)%
$
166.8
$
161.8
3.1
%
$
641.1
$
638.1
0.5
%
Animal Safety:
Life Sciences
1.8
1.6
12.5
%
6.6
6.5
1.5
%
Veterinary Instruments & Disposables
15.8
16.1
(1.9
)%
56.9
61.5
(7.5
)%
Animal Care & Other
7.0
8.0
(12.5
)%
29.3
34.7
(15.6
)%
Rodent Control, Insect Control & Disinfectants
16.7
21.5
(22.3
)%
68.9
88.1
(21.8
)%
Genomics Services
17.2
16.5
4.2
%
67.6
65.8
2.7
%
$
58.5
$
63.7
(8.2
)%
$
229.3
$
256.6
(10.6
)%
Total Revenue, net
$
225.3
$
225.5
(0.1
)%
$
870.4
$
894.7
(2.7
)%
Three months ended May 31,
Twelve months ended May 31,
2026
2025
Change %
2026
2025
Change %
Domestic
110.3
$
112.5
(2.0
)%
$
425.1
$
446.0
(4.7
)%
International
115.0
113.0
1.8
%
$
445.3
448.7
(0.8
)%
Total revenue
$
225.3
$
225.5
(0.1
)%
$
870.4
$
894.7
(2.7
)%
• Revenues for the fourth quarter were $225.3 million, growth of (0.1%) when compared to $225.5 million in the prior year. Core revenue, which excludes the impacts of foreign currency translation, as well as divestitures completed and product lines discontinued in the last 12 months, increased by 4.3%, the highest rate in fiscal year 2026.
• Food Safety segment revenue was $166.8 million in the fourth quarter, increasing 3.1% relative to the fourth quarter of fiscal year 2025. Core Food Safety revenue growth increased 5.8% on a year-over-year basis, the highest rate since the period immediately following the acquisition of the 3M® Food Safety business in FY23. The Company saw continued strong growth in Indicator Testing and Culture Media which was up 9.5% in the fourt
Apr 9, 2026 · 100% conf.
1D
-0.37%
$10.00
Act: -5.78%
5D
-5.76%
$9.46
Act: -7.92%
20D
-1.82%
$9.85
Act: -7.82%
2 neog-ex99_1.htm
Exhibit 99.1
Neogen Reports Third Quarter Fiscal Year 2026 Financial Results
• Fiscal third quarter 2026 revenue of $211.2 million
• Food Safety revenue growth of 2.6%, Core Growth1 of 4.0%; Animal Safety revenue growth of (20.1%), Core Growth1 of (8.7%) due primarily to third-party supplier challenges in the quarter
• Net loss of $17.0 million in the third quarter 2026 with GAAP EPS of $(0.08), Adjusted Net Income of $19.4 million and Adjusted EPS of $0.09
• Third quarter 2026 cash flow from operations of $22.7 million and free cash flow of $11.1 million
• Adjusted EBITDA1 of $48.2 million; Adjusted EBITDA margins1 of 22.8% increases sequentially by 110 basis points
• Petrifilm® manufacturing transition remains on track for November FY27; Company has initiated operational and performance validation on multiple single kit units (SKUs)
• Divestiture of Genomics business unit announced and anticipated to close in 2Q27; Net cash proceeds support net debt-to-adjusted EBITDA1 of less than three times by end of CY2026
• Raising fiscal year 2026 revenue outlook and maintaining Adjusted EBITDA guidance
1 Non-GAAP financial measures; see explanations and reconciliations that follow
LANSING, April 9, 2026 – Neogen® Corporation (NASDAQ: NEOG), an innovative leader in food safety solutions, announced its financial results for the fiscal third quarter of 2026 and provided updated full fiscal year 2026 financial guidance.
“We continued to make significant progress on our strategic transformation in the third quarter as we look to stabilize and strengthen our core business. We are emboldened by the continued strength in core growth in our Food Safety segment. Combined with our major strategic sales initiatives such as our go-to-market strategy review, our increasing use of metric-based key performance indicators, and our transition to a standardized global solutions based selling approach, we believe we are well positioned for continued fundamental improvement across the organization," said Mike Nassif, Neogen’s Chief Executive Officer and President.
He continued, “In the third quarter our Animal Safety business suffered several third-party, supply-based, setbacks leading to lower-than-anticipated growth, and we are actively engaged in improving these production-related challenges through our supplier qualification and sales and operations planning process. Despite these transient issues, we were able to deliver strong adjusted EBITDA through solid cost control and we continue to see opportunities to drive efficiency through technology and process across the company. We are confident that we will emerge from this fiscal year stronger and more capable as an organization, and increasingly focused on building upon our market leading position in Food Safety through discipline, improved enterprise capabilities, a renewed focus on innovation leadership, and a dramatically improved selling process.”
Financial Highlights
Revenue by Products and Geography
Three months ended February 28,
Nine months ended February 28,
2026
2025
Change %
2026
2025
Change %
Food Safety
Natural Toxins & Allergens
$
17.9
$
17.6
1.7
%
$
58.3
$
58.5
(0.3
)%
Bacterial & General Sanitation
42.1
39.9
5.5
%
128.7
122.3
5.2
%
Indicator Testing & Culture Media
83.0
74.8
11.0
%
245.9
232.9
5.6
%
Biosecurity Products
3.9
11.8
(66.9
)%
14.3
35.7
(59.9
)%
Genomics Services
6.2
5.7
8.8
%
18.0
17.1
5.3
%
Other
3.6
3.0
20.0
%
9.1
9.8
(7.1
)%
Total Food Safety Revenue
$
156.7
$
152.8
2.6
%
$
474.3
$
476.3
(0.4
)%
Animal Safety
Life Sciences
$
1.5
$
1.5
—
$
4.8
$
4.9
(2.0
)%
Veterinary Instruments & Disposables
15.5
15.5
—
41.1
45.4
(9.5
)%
Animal Care & Other
5.9
10.4
(43.3
)%
22.3
26.7
(16.5
)%
Biosecurity Products
15.0
23.8
(37.0
)%
52.2
66.6
(21.6
)%
Genomics Services
16.6
17.0
(2.4
)%
50.4
49.3
2.2
%
Total Animal Safety Revenue
$
54.5
$
68.2
(20.1
)%
$
170.8
$
192.9
(11.5
)%
Total Revenues
$
211.2
$
221.0
(4.4
)%
$
645.1
$
669.2
(3.6
)%
Three months ended February 28,
Nine months ended February 28,
2026
2025
Change %
2026
2025
Change %
Domestic
$
102.3
$
115.4
(11.4
)%
$
314.8
$
333.5
(5.6
)%
International
108.9
105.6
3.1
%
330.3
335.7
(1.6
)%
Total revenue
$
211.2
$
221.0
(4.4
)%
$
645.1
$
669.2
(3.6
)%
• Revenues for the third quarter were $211.2 million, a decrease of 4.4% when compared to $221.0 million in the prior year. Core revenue, which excludes the impacts of foreign currency translation, as well as divestitures completed and product lines discontinued in the last 12 months, increased by 0.1%.
• Food Safety segment revenue was $156.7 million in the third quarter, increasing 2.6% relative to the third quarter of fiscal year 2025. Core Food Safety revenue increased 4.0% on a year-over-year basis. The c
This page provides Neogen Corporation (NEOG) earnings call transcripts from SEC 8-K filings along with AI-powered predictions for post-earnings price movements. Our machine learning models analyze historical earnings data, pre-earnings price patterns, volume changes, and volatility to predict 1-day, 5-day, and 20-day returns after each earnings release.
Earnings transcripts are sourced directly from SEC EDGAR filings. Predictions are generated using gradient boosting models trained on NEOG's historical earnings reactions. All predicted returns are shown as percentages, and predicted prices are calculated from the closing price at the time of prediction. Past performance does not guarantee future results.